Enviracor J-5 (Canada)This page contains information on Enviracor J-5 for veterinary use.
The information provided typically includes the following:
- Enviracor J-5 Indications
- Warnings and cautions for Enviracor J-5
- Direction and dosage information for Enviracor J-5
Enviracor J-5This treatment applies to the following species:
Escherichia Coli Bacterin J-5 Strain
For veterinary use only
Enviracor® J-5 Bacterin is recommended for use in healthy dairy cattle as an aid in the reduction of shedding of E. coli in the milk due to mastitis. For effective mastitis control this product should be used in conjunction with acceptable good management practices.
Directions For Use
Shake well. Three doses are required. Administer each 5-mL dose subcutaneously, one hand-width cranial to the shoulder. Vaccinate cows or heifers at both 7 and 8 months of gestation followed by the third dose within two weeks postpartum.
PrecautionsStore at 2°-8°C. Do not freeze. Use entire contents when first opened. No milk discard is required. Do not vaccinate within 60 days before slaughter. Local swelling occasionally occurs and may persist at the injection site. Contains thimerosal as a preservative. Do not mix with other products. In case of human exposure contact a physician. In case of anaphylactoid reactions, epinephrine should be administered immediately.
For technical assistance 1-800-461-0917.
Distributed in Canada by: Zoetis Inc., Kalamazoo, MI 49007, USA
Manufactured by: PHL Associates, Inc., Davis, CA USA 95616
VLN 357/PCN 2648.00
16,740 TRANS-CANADA HIGHWAY, KIRKLAND, QC, H9H 4M7
|Technical Services Canada:||800-461-0917|
|Technical Services USA:||800-366-5288|
|Every effort has been made to ensure the accuracy of the Enviracor J-5 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2020 Animalytix LLC. Updated: 2020-10-21